Harel buys Givat Shmuel mall

Gindi Investments, the construction and development group that is responsible for building many of the new neighborhoods in Rishon Lezion, has sold the "Kenyon Hagiva" mall, currently under construction in Givat Shmuel, for NIS 120 million to finance and insurance company Harel.

By MATTHEW KRIEGER
April 4, 2007 06:51

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Gindi Investments, the construction and development group that is responsible for building many of the new neighborhoods in Rishon Lezion, has sold the "Kenyon Hagiva" mall, currently under construction in Givat Shmuel, for NIS 120 million to finance and insurance company Harel. The mall was built in the style of a "streetmall" and 80% of the available rental space has already been filled by national retail and food chains including FOX clothing, Steimatsky, New-Farm and McDonald's. The mall is slated to open at the beginning of 2008.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS